Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Technology Scientific & Technical Instruments

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Comment by funky99on Jul 07, 2016 3:01pm

90 Views

Post# 25032854

RE:RE:RE:Jonathan Goodman

Also check Antibe Therapeutics ATE.V for which Jonathan Goodman was on the board and still owns shares. He also invested in Antibe Therapeutics via his company Knight Therapeutics GUD.TO and via the Bloom Burton Healthcare fund. Another one to keep on the list with Profound PRN.V. Everything Goodman seems to be involved, shareholders gets rewarded.

Bullboard Posts

The top 10 Canadian medical stocks